Indications and uses
For temporary use in cleansing minor wounds or minor gum inflammation resulting from minor dental procedures, dentures, orthodontic appliances, accidental injury, or other irritations of the mouth and gums.
For temporary use in cleansing minor wounds or minor gum inflammation resulting from minor dental procedures, dentures, orthodontic appliances, accidental injury, or other irritations of the mouth and gums.
Apply several drops to the affected area of the mouth. Allow medication to remain in place at least 1 minute and then spit out. Use up to 4 times daily after meals and at bedtime or as directed by a dentist or doctor. Children under 12 years of age should be supervised in the use of this product. Children under 2 years of age: Consult a dentist or doctor.
Store at controlled room temperature (68°-77°F) in a cool, dry place away from direct sunlight.
Drug Facts
Hydrogen peroxide 1.7% (w/w)
Oral Debriding Agent/Oral Wound Cleanser
For temporary use in cleansing minor wounds or minor gum inflammation resulting from minor dental procedures, dentures, orthodontic appliances, accidental injury, or other irritations of the mouth and gums.
Do not use for more than 7 days unless directed by a dentist or doctor. Spit out excess medication.
Stop use and ask a doctor if
Keep out of reach of children.
Store at controlled room temperature (68°-77°F) in a cool, dry place away from direct sunlight.
Inactive ingredients: ethyl alcohol (5% w/w), menthol, methyl salicylate, phosphoric acid, poloxamer 407, polysorbate 20, potassium sorbate, sodium saccharin, sorbitol, water.
Call toll free 1-877-907-3746 from 9am - 5pm CST/CDT Monday-Friday.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1095271 | hydrogen peroxide 1.7 % Oral Gel | PSN | 4 |
| 2743349 | PerioGel 1.7 % Oral Gel | PSN | 4 |
| 2743349 | hydrogen peroxide 0.017 MG/MG Oral Gel [Periogel] | SBD | 4 |
| 1095271 | hydrogen peroxide 0.017 MG/MG Oral Gel | SCD | 4 |
| 1095271 | hydrogen peroxide 1.7 % Oral Gel | SY | 4 |
| 2743349 | Periogel 0.017 MG/MG Oral Gel | SY | 4 |
| 2743349 | Periogel 1.7 % Oral Gel | SY | 4 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5eb9f24b-9328-475e-af0a-18021935eb6a | Product name | 1 | 20180220 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 75908-017-28 | 2024-01-30 | C162847 | 48780-1 | d6a99b39-36da-a426-e053-dadaa90af4c2 | Periogel ® |
| 75908-017-85 | 2024-01-30 | C162847 | 48780-1 | d6a99b39-36da-a426-e053-dadaa90af4c2 | Periogel ® |
| 75908-017-28 | 2022-05-16 | C162847 | 48780-1 | d6a99b39-36da-a426-e053-dadaa90af4c2 | Periogel ® |
| 75908-017-85 | 2022-05-16 | C162847 | 48780-1 | d6a99b39-36da-a426-e053-dadaa90af4c2 | Periogel ® |
| 75908-017-28 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-36da-a426-e053-dadaa90af4c2 | Periogel ® |
| 75908-017-85 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-36da-a426-e053-dadaa90af4c2 | Periogel ® |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75908-017-28 | Periogel | 1 in 1 CARTON | GEL | 1 | 4 | |
| 75908-017-28 | Periogel | 28.3 g in 1 TUBE | GEL | 28.3 | 4 | |
| 75908-017-85 | Periogel | 85 g in 1 TUBE | GEL | 85 | 4 | |
| 75908-017-85 | Periogel | 1 in 1 CARTON | GEL | 1 | 4 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| hydrogen peroxide | ACTIVE INGREDIENT | BBX060AN9V | 2 | |
| hydrogen peroxide | ACTIVE MOIETY | BBX060AN9V | 2 | |
| alcohol | INACTIVE INGREDIENT | 3K9958V90M | 2 | |
| menthol | INACTIVE INGREDIENT | L7T10EIP3A | 2 | |
| methyl salicylate | INACTIVE INGREDIENT | LAV5U5022Y | 2 | |
| phosphoric acid | INACTIVE INGREDIENT | E4GA8884NN | 2 | |
| poloxamer 407 | INACTIVE INGREDIENT | TUF2IVW3M2 | 2 | |
| polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 2 | |
| potassium sorbate | INACTIVE INGREDIENT | 1VPU26JZZ4 | 2 | |
| saccharin sodium | INACTIVE INGREDIENT | SB8ZUX40TY | 2 | |
| sorbitol | INACTIVE INGREDIENT | 506T60A25R | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 75908-017 | 75908-017-85, 75908-017-28 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| hydrogen peroxide | BBX060AN9V | ACTIB |
| alcohol | 3K9958V90M | IACT |
| menthol, unspecified form | L7T10EIP3A | IACT |
| methyl salicylate | LAV5U5022Y | IACT |
| phosphoric acid | E4GA8884NN | IACT |
| poloxamer 407 | TUF2IVW3M2 | IACT |
| polysorbate 20 | 7T1F30V5YH | IACT |
| potassium sorbate | 1VPU26JZZ4 | IACT |
| saccharin sodium | SB8ZUX40TY | IACT |
| sorbitol | 506T60A25R | IACT |
| water | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| sorbitol | SORBITOL | 506T60A25R | INJECTION, SOLUTION / SUBCUTANEOUS | 4.7 %w/v | ||
| poloxamer 407 | POLOXAMER 407 | TUF2IVW3M2 | SOLUTION / OPHTHALMIC | 0.2 %w/v | ||
| alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| saccharin sodium | SACCHARIN SODIUM | SB8ZUX40TY | TABLET / SUBLINGUAL | 7 mg | ||
| poloxamer 407 | POLOXAMER 407 | TUF2IVW3M2 | SOLUTION / ORAL | 50 mg/5ml | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CREAM / TOPICAL | 108 mg | ||
| saccharin sodium | SACCHARIN SODIUM | SB8ZUX40TY | TABLET, CHEWABLE / ORAL | 84 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | ADJ PH | ||
| menthol | MENTHOL | L7T10EIP3A | TABLET / ORAL | 0.58 mg | ||
| menthol | MENTHOL | L7T10EIP3A | POWDER, FOR SOLUTION / ORAL | NA | ||
| saccharin sodium | SACCHARIN SODIUM | SB8ZUX40TY | POWDER, FOR SUSPENSION / ORAL | 85 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | ||
| sorbitol | SORBITOL | 506T60A25R | AEROSOL, FOAM / TOPICAL | 4.95 %w/w | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, FILM COATED / ORAL | 0.35 mg | ||
| saccharin sodium | SACCHARIN SODIUM | SB8ZUX40TY | SUSPENSION / RECTAL | 290 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRAMUSCULAR | NA | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SOLUTION / TOPICAL | 15 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| sorbitol | SORBITOL | 506T60A25R | POWDER, FOR SUSPENSION / ORAL | 12000 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | PASTE, DENTIFRICE / DENTAL | ADJ PH | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | POWDER, FOR SUSPENSION / ORAL | 1.3 mg/5ml | ||
| menthol | MENTHOL | L7T10EIP3A | CREAM / TOPICAL | 0.1 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| menthol | MENTHOL | L7T10EIP3A | DROPS / NASAL | 40.32 mg | ||
| menthol | MENTHOL | L7T10EIP3A | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | GEL / TOPICAL | 5 %w/w | ||
| saccharin sodium | SACCHARIN SODIUM | SB8ZUX40TY | OINTMENT / TOPICAL | NA | ||
| alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| menthol | MENTHOL | L7T10EIP3A | TABLET / SUBLINGUAL | 2 mg | ||
| sorbitol | SORBITOL | 506T60A25R | PASTE, DENTIFRICE / DENTAL | 14 %w/w | ||
| sorbitol | SORBITOL | 506T60A25R | CREAM / TOPICAL | 36.8 %w/w | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, EXTENDED RELEASE / ORAL | 4.2 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| sorbitol | SORBITOL | 506T60A25R | OINTMENT / TOPICAL | 10 %w/w | ||
| sorbitol | SORBITOL | 506T60A25R | TABLET / SUBLINGUAL | 50.5 mg | ||
| menthol | MENTHOL | L7T10EIP3A | LOTION / TOPICAL | 0.05 %w/w | ||
| menthol | MENTHOL | L7T10EIP3A | PASTE, DENTIFRICE / DENTAL | 4.7 %w/w | ||
| sorbitol | SORBITOL | 506T60A25R | LIQUID / ORAL | 53460 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | INJECTION / INTRALESIONAL | ADJ PH | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / ORAL | 80 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| poloxamer 407 | POLOXAMER 407 | TUF2IVW3M2 | CAPSULE, DELAYED RELEASE / ORAL | 5 mg | ||
| saccharin sodium | SACCHARIN SODIUM | SB8ZUX40TY | POWDER, FOR SOLUTION / ORAL | 199 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| potassium sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / SUBCUTANEOUS | NA | ||
| saccharin sodium | SACCHARIN SODIUM | SB8ZUX40TY | INJECTION / INTRAVENOUS | 22 mg | ||
| sorbitol | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| sorbitol | SORBITOL | 506T60A25R | GUM, CHEWING / ORAL | 6168 mg | ||
| saccharin sodium | SACCHARIN SODIUM | SB8ZUX40TY | GRANULE, FOR SOLUTION / ORAL | 5.5 mg/120ml | ||
| sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRA-ARTICULAR | 45 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4539ba00-922d-473d-8c61-2fa0c3ef5e97 | 30f97d9b-7551-499f-b3bb-5a658bd3a493 | 2022-05-13 | Warnings | 4539ba00-922d-473d-8c61-2fa0c3ef5e97 30f97d9b-7551-499f-b3bb-5a658bd3a493 |
Adverse event summaries are temporarily unavailable. Other product information remains available.